Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 22, 2015
In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens
Douglas J Biedenbach, Michael D Huband, Meredith Hackel, et al.
Antimicrobial Agents and Chemotherapy
|
March 2, 2016
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
Boudewijn L M de Jonge, James A Karlowsky, Krystyna M Kazmierczak, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2018
<i>In Vitro</i> Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015
James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2017
<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015
James A Karlowsky, Krystyna M Kazmierczak, Boudewijn L M de Jonge, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2019
<i>In Vitro</i> Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015
James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2017
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii
Sarah M McLeod, Adam B Shapiro, Samir H Moussa, et al.
Antimicrobial Agents and Chemotherapy
|
May 25, 2016
Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014
Meredith Hackel, Krystyna M Kazmierczak, Daryl J Hoban, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2016
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
Krystyna M Kazmierczak, Douglas J Biedenbach, Meredith Hackel, et al.
Nature
|
June 15, 2007
Exploitation of structural and regulatory diversity in glutamate racemases
Tomas Lundqvist, Stewart L Fisher, Gunther Kern, et al.
Antimicrobial Agents and Chemotherapy
|
September 24, 2014
A novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteria
Jun Fan, Boudewijn L M de Jonge, Kathy MacCormack, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Antimicrobial Agents and Chemotherapy
|
July 22, 2015
In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens
Douglas J Biedenbach, Michael D Huband, Meredith Hackel, et al.
Antimicrobial Agents and Chemotherapy
|
March 2, 2016
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
Boudewijn L M de Jonge, James A Karlowsky, Krystyna M Kazmierczak, et al.
Antimicrobial Agents and Chemotherapy
|
May 16, 2018
<i>In Vitro</i> Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015
James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2017
<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015
James A Karlowsky, Krystyna M Kazmierczak, Boudewijn L M de Jonge, et al.
Antimicrobial Agents and Chemotherapy
|
January 24, 2019
<i>In Vitro</i> Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015
James A Karlowsky, Krystyna M Kazmierczak, Samuel K Bouchillon, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2017
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii
Sarah M McLeod, Adam B Shapiro, Samir H Moussa, et al.
Antimicrobial Agents and Chemotherapy
|
May 25, 2016
Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014
Meredith Hackel, Krystyna M Kazmierczak, Daryl J Hoban, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2016
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
Krystyna M Kazmierczak, Douglas J Biedenbach, Meredith Hackel, et al.
Nature
|
June 15, 2007
Exploitation of structural and regulatory diversity in glutamate racemases
Tomas Lundqvist, Stewart L Fisher, Gunther Kern, et al.
Antimicrobial Agents and Chemotherapy
|
September 24, 2014
A novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteria
Jun Fan, Boudewijn L M de Jonge, Kathy MacCormack, et al.
Page
of 3